| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection
|
Wu, Yi-Long
|
|
2018
|
19 |
4 |
p. e533-e536
|
artikel
|
| 2 |
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
|
Wu, Yi-Long
|
|
2018
|
19 |
4 |
p. e465-e479
|
artikel
|
| 3 |
Atezolizumab in Japanese Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study
|
Hida, Toyoaki
|
|
2018
|
19 |
4 |
p. e405-e415
|
artikel
|
| 4 |
Clinical and Molecular Predictors of PD-L1 Expression in Non–Small-Cell Lung Cancer: Systematic Review and Meta-analysis
|
Petrelli, Fausto
|
|
2018
|
19 |
4 |
p. 315-322
|
artikel
|
| 5 |
Clinical Implications of the BIM Deletion Polymorphism in Advanced Lung Adenocarcinoma Treated With Gefitinib
|
Yuan, Jupeng
|
|
2018
|
19 |
4 |
p. e431-e438
|
artikel
|
| 6 |
Clinicopathologic Features and Immune Microenvironment of Non–Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
|
Takashima, Yuta
|
|
2018
|
19 |
4 |
p. 352-359.e1
|
artikel
|
| 7 |
Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non–Small-Cell Lung Cancer After Definitive Radiation Therapy
|
Kim, Charissa R.
|
|
2018
|
19 |
4 |
p. e517-e528
|
artikel
|
| 8 |
Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non–small-cell Lung Cancer
|
Qiu, Tian
|
|
2018
|
19 |
4 |
p. e391-e398
|
artikel
|
| 9 |
Editorial Board
|
|
|
2018
|
19 |
4 |
p. A6
|
artikel
|
| 10 |
Fatal Radiation Pneumonitis in Patients With Subclinical Interstitial Lung Disease
|
Niska, Joshua R.
|
|
2018
|
19 |
4 |
p. e417-e420
|
artikel
|
| 11 |
Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices
|
Bernhardt, Denise
|
|
2018
|
19 |
4 |
p. 340-345
|
artikel
|
| 12 |
Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma
|
Liu, Yiwei
|
|
2018
|
19 |
4 |
p. e421-e430
|
artikel
|
| 13 |
KMT2D Mutation Is Associated With Poor Prognosis in Non–Small-Cell Lung Cancer
|
Ardeshir-Larijani, Fatemeh
|
|
2018
|
19 |
4 |
p. e489-e501
|
artikel
|
| 14 |
Letter to the Editor
|
Fumagalli, Caterina
|
|
2018
|
19 |
4 |
p. e439-e440
|
artikel
|
| 15 |
Making the Evidentiary Case for Universal Multidisciplinary Thoracic Oncologic Care
|
Osarogiagbon, Raymond U.
|
|
2018
|
19 |
4 |
p. 294-300
|
artikel
|
| 16 |
MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
|
Reis, Henning
|
|
2018
|
19 |
4 |
p. e441-e463
|
artikel
|
| 17 |
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies
|
Hirsch, Fred R.
|
|
2018
|
19 |
4 |
p. 331-339
|
artikel
|
| 18 |
Multidisciplinary Clinics in Lung Cancer Care: A Systematic Review
|
Stone, Christopher J.L.
|
|
2018
|
19 |
4 |
p. 323-330.e3
|
artikel
|
| 19 |
Non–small-cell Lung Cancer With Brain Metastasis at Presentation
|
Waqar, Saiama N.
|
|
2018
|
19 |
4 |
p. e373-e379
|
artikel
|
| 20 |
Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non–Small-Cell Lung Cancer
|
Grilley-Olson, Juneko E.
|
|
2018
|
19 |
4 |
p. e481-e487
|
artikel
|
| 21 |
Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy
|
Zheng, Ye
|
|
2018
|
19 |
4 |
p. e399-e404
|
artikel
|
| 22 |
Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns
|
Farrell, Matthew J.
|
|
2018
|
19 |
4 |
p. 371-376
|
artikel
|
| 23 |
Second-Line Treatment Options in Non–Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology
|
Gridelli, Cesare
|
|
2018
|
19 |
4 |
p. 301-314
|
artikel
|
| 24 |
SUNSET: Stereotactic Radiation for Ultracentral Non–Small-Cell Lung Cancer—A Safety and Efficacy Trial
|
Giuliani, Meredith
|
|
2018
|
19 |
4 |
p. e529-e532
|
artikel
|
| 25 |
Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach
|
Bilfinger, Thomas V.
|
|
2018
|
19 |
4 |
p. 346-351
|
artikel
|
| 26 |
Table of Contents
|
|
|
2018
|
19 |
4 |
p. A7-A9, A15-A16
|
artikel
|
| 27 |
The Road Less Traveled: Should We Omit Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer?
|
Sio, Terence T.
|
|
2018
|
19 |
4 |
p. 289-293
|
artikel
|
| 28 |
Treatment Patterns and Clinical Outcomes Among Metastatic Non–Small-Cell Lung Cancer Patients Treated in the Community Practice Setting
|
Nadler, Eric
|
|
2018
|
19 |
4 |
p. 360-370
|
artikel
|
| 29 |
Treatment Satisfaction of Patients With Advanced Non–Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL)
|
Visser, Sabine
|
|
2018
|
19 |
4 |
p. e503-e516
|
artikel
|
| 30 |
Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non–Small Cell Lung Cancer Are Associated With Decreases in Overall Survival
|
Deek, Matthew P.
|
|
2018
|
19 |
4 |
p. e381-e390
|
artikel
|
Tijdschrift beschrijving